Literature DB >> 3186758

Ex vivo model of an immobilized-enzyme reactor.

H Bernstein1, R Langer.   

Abstract

Immobilized-enzyme reactors are beginning to be studied for a variety of therapeutic applications. To facilitate the design of these devices for different clinical situations and a diverse patient population, mathematical models may be valuable. An immobilized-heparinase (EC 4.2.2.7) reactor was selected as a model system. The device removes heparin from blood that has been anticoagulated to prevent thrombus formation. Heparinase was immobilized to cross-linked agarose particles. A mathematical model was developed to describe the clearance of heparin by the reactor ex vivo and compared to experimental clearances measured in sheep. The model accounted for enzymatic degradation as well as the binding of heparin and its breakdown products to antithrombin. The device was modeled as a steady-state continuously stirred tank reactor. Molar conservation equations within the agarose particles accounted for simultaneous diffusion and chemical reaction. The model had no adjustable parameters and was able to predict the clearance of heparin within 5-25% for three different animals and 12 different perfusions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3186758      PMCID: PMC282539          DOI: 10.1073/pnas.85.22.8751

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

Review 2.  Biologic actions of heparin.

Authors:  R D Rosenberg
Journal:  Semin Hematol       Date:  1977-10       Impact factor: 3.851

3.  L-asparaginase tubes: kinetic behavior and application in physiological studies.

Authors:  C Horvath; A Sardi; J S Woods
Journal:  J Appl Physiol       Date:  1973-02       Impact factor: 3.531

4.  Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.

Authors:  M J Griffith
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

5.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.

Authors:  R E Jordan; G M Oosta; W T Gardner; R D Rosenberg
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

6.  Immobilized carboxypeptidase G1 in methotrexate removal.

Authors:  J R Bertino; S Condos; C Horvath; K Kalghatgi; H Pedersen
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

7.  Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.

Authors:  R J Linhardt; A Grant; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  Evaluation of critical groups required for the binding of heparin to antithrombin.

Authors:  D H Atha; A W Stephens; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Extracorporeal enzymatic heparin removal: use in a sheep dialysis model.

Authors:  H Bernstein; V C Yang; D Lund; M Randhawa; W Harmon; R Langer
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

10.  Heparinase production by Flavobacterium heparinum.

Authors:  P M Galliher; C L Cooney; R Langer; R J Linhardt
Journal:  Appl Environ Microbiol       Date:  1981-02       Impact factor: 4.792

View more
  2 in total

1.  Bioreactor based on suspended particles of immobilized enzyme.

Authors:  L E Freed; G V Vunjak-Novakovic; P A Drinker; R Langer
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

2.  Kinetics of immobilized heparinase in human blood.

Authors:  L E Freed; G V Vunjak-Novakovic; H Bernstein; C L Cooney; R Langer
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.